PEN (STOCKS)
Penumbra, Inc.
$331.480000
+1.710000 (+0.52%)
Prev close: $329.770000
Company Information
- Exchange
- XNYS
- Sector
- Health Technology
- Industry
- Medical Specialties
- CEO
- Adam Elsesser
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $13,031.02M
- Employees
- 4,500
- P/E (TTM)
- 72.92
- P/B (TTM)
- 9.06
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
3
Strong Buy
5
Buy
14
Hold
0
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Dec 2025 (Q4)
|
$1.18 | $1.12 | +0.0564 | +5.02% |
|
Sep 2025 (Q3)
|
$0.97 | $0.93 | +0.0393 | +4.22% |
|
Jun 2025 (Q2)
|
$0.86 | $0.83 | +0.0301 | +3.63% |
|
Mar 2025 (Q1)
|
$0.83 | $0.67 | +0.1599 | +23.86% |
Financial Statements
| Revenues | $1.40B |
| Benefits Costs and Expenses | $1.20B |
| Cost Of Revenue | $461.23M |
| Costs And Expenses | $1.20B |
| Gross Profit | $942.44M |
| Nonoperating Income/Loss | $15.88M |
| Operating Expenses | $753.19M |
| Selling, General, and Administrative Expenses | $663.42M |
| Other Operating Expenses | $89.77M |
| Operating Income/Loss | $189.25M |
| Income/Loss From Continuing Operations After Tax | $177.69M |
| Income/Loss From Continuing Operations Before Tax | $205.13M |
| Income Tax Expense/Benefit | $27.44M |
| Income Tax Expense/Benefit, Current | $6.44M |
| Income Tax Expense/Benefit, Deferred | $21.00M |
| Net Income/Loss | $177.69M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | $177.69M |
| Net Income/Loss Available To Common Stockholders, Basic | $177.69M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | $4.57 |
| Diluted Earnings Per Share | $4.52 |
| Basic Average Shares | 38,918,493 |
| Diluted Average Shares | 39,291,828 |
| Assets | $1.83B |
| Current Assets | $1.22B |
| Inventory | $431.55M |
| Other Current Assets | $785.14M |
| Noncurrent Assets | $609.84M |
| Fixed Assets | $117.44M |
| Intangible Assets | $6.19M |
| Other Non-current Assets | $486.21M |
| Liabilities | $398.92M |
| Current Liabilities | $183.13M |
| Accounts Payable | $34.74M |
| Wages | $85.40M |
| Other Current Liabilities | $63.00M |
| Noncurrent Liabilities | $215.78M |
| Equity | $1.43B |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $1.43B |
| Liabilities And Equity | $1.83B |
| Net Cash Flow From Operating Activities | $238.66M |
| Net Cash Flow From Operating Activities, Continuing | $238.66M |
| Net Cash Flow From Investing Activities | -$404.59M |
| Net Cash Flow From Investing Activities, Continuing | -$404.59M |
| Net Cash Flow From Financing Activities | $26.53M |
| Net Cash Flow From Financing Activities, Continuing | $26.53M |
| Exchange Gains/Losses | $1.89M |
| Net Cash Flow | -$137.51M |
| Net Cash Flow, Continuing | -$139.40M |
| Comprehensive Income/Loss | $187.88M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | $187.88M |
| Other Comprehensive Income/Loss | $10.19M |
| Other Comprehensive Income/Loss Attributable To Parent | $10.19M |